Alternative payment and care-delivery models in oncology: A systematic review

Cancer
Emeline M AvikiDeborah Korenstein

Abstract

Rising US health care costs have led to the creation of alternative payment and care-delivery models designed to maximize outcomes and/or minimize costs through changes in reimbursement and care delivery. The impact of these interventions in cancer care is unclear. This review was undertaken to describe the landscape of new alternative payment and care-delivery models in cancer care. In this systematic review, 22 alternative payment and/or care-delivery models in cancer care were identified. These included 6 bundled payments, 4 accountable care organizations, 9 patient-centered medical homes, and 3 other interventions. Only 12 interventions reported outcomes; the majority (n = 7; 58%) improved value, 4 had no impact, and 1 reduced value, but only initially. Heterogeneity of outcomes precluded a meta-analysis. Despite the growth in alternative payment and delivery models in cancer, there is limited evidence to evaluate their efficacy. Cancer 2018. © 2018 American Cancer Society.

References

Dec 15, 2010·The New England Journal of Medicine·Michael E Porter
Jan 14, 2011·Journal of the National Cancer Institute·Angela B MariottoMartin L Brown
Sep 4, 2012·Journal of Oncology Practice·Linda D BossermanWendy McNatt
Sep 4, 2012·Journal of Oncology Practice·John D Sprandio
Aug 29, 2013·JAMA : the Journal of the American Medical Association·J Michael McWilliamsMichael E Chernew
Jul 6, 2014·Journal of Oncology Practice·Gordon KuntzKurt Neumann
Jul 10, 2014·Journal of Oncology Practice·Lee N NewcomerMonica Perkins
Jul 30, 2014·Healthcare : the Journal of Delivery Science and Innovation·Carrie H CollaElliott S Fisher
Jan 4, 2015·BMJ : British Medical Journal·Larissa ShamseerUNKNOWN PRISMA-P Group
Jan 27, 2015·The New England Journal of Medicine·Sylvia M Burwell
Apr 16, 2015·The New England Journal of Medicine·J Michael McWilliamsAaron L Schwartz
Jul 30, 2015·Journal of Oncology Practice·Teresa M WatersBarbara L McAneny
Oct 1, 2015·Journal of Oncology Practice·Manasi A TirodkarSarah Hudson Scholle
Jan 27, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Scott D RamseyPolly Newcomb
Apr 15, 2016·The New England Journal of Medicine·J Michael McWilliamsAaron L Schwartz
Aug 18, 2016·JAMA : the Journal of the American Medical Association·Zirui Song, Elliott S Fisher
Aug 18, 2016·JAMA : the Journal of the American Medical Association·Kevin A Schulman, Barak D Richman
Feb 27, 2017·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Jeanne S MandelblattCharles E Phelps
Mar 23, 2017·Journal of Oncology Practice·UNKNOWN American Society of Clinical Oncology
Jun 7, 2017·JAMA : the Journal of the American Medical Association·Ethan BaschDeborah Schrag

❮ Previous
Next ❯

Citations

Dec 21, 2018·JAMA Oncology·Emeline M AvikiSamyukta Mullangi
Dec 6, 2019·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Meng LiDana P Goldman
Apr 3, 2020·American Society of Clinical Oncology Educational Book·Devika DasGabrielle Rocque
Apr 18, 2020·JCO Oncology Practice·Jeffrey C WardMary Rappaport
Apr 26, 2019·Journal of Oncology Practice·Arthur S HongEthan A Halm
Mar 25, 2020·Applied Health Economics and Health Policy·Ann-Kathrin Heider, Harald Mang
Aug 1, 2020·The Cancer Journal·Erlene K SeymourA Mark Fendrick
Jan 1, 2019·International Journal of Care Coordination·W H van Harten
Aug 1, 2020·The Cancer Journal·Lee N Newcomer
Jun 1, 2020·Bone Marrow Transplantation·Salvatore FiorenzaJoshua A Roth
May 18, 2020·Annals of Surgical Oncology·Rachel A GreenupCorinna Sorenson
Oct 14, 2020·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Benjamin B AlbrightAshley F Haggerty
Feb 6, 2020·The Journal of the American Academy of Orthopaedic Surgeons·Azeem Tariq MalikThomas J Scharschmidt
Nov 14, 2020·International Journal of Environmental Research and Public Health·Rick A VremanWim G Goettsch
Jul 1, 2021·Implementation Science : IS·Alex R DoppRamesh Raghavan
Jul 14, 2021·JCO Oncology Practice·Kim WoofterJohn V Cox
Oct 7, 2021·JAMA Network Open·Carolyn Y Fang, Zachary A K Frosch
Nov 10, 2021·JAMA : the Journal of the American Medical Association·Nancy L KeatingUNKNOWN Oncology Care Model Evaluation Team

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.